| |
| |
|
| Insider
Information: |
Fraser Craig |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
55,377 |
|
|
Indirect Shares
|
3 |
|
|
| Direct
Value |
$9,082 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,380 |
|
|
| Total
Value |
$9,082 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
23
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
23
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-23.0
|
0.0
|
| Percentage
Gain/Loss : |
 -54.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aegerion Pharmaceuticals, Inc. |
AEGR |
Pres., US/Int. Comm. &... |
2014-04-30 |
0 |
2013-10-07 |
0 |
Premium* |
|
|
Windtree Therapeutics Inc |
WINT |
President and CEO, Dir... |
2023-09-26 |
55,377 |
2023-09-26 |
3 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2016-06-30 |
4 |
A |
$1.93 |
$2,081 |
I/I |
1,078 |
1,078 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2021-04-16 |
4 |
B |
$2.09 |
$2,092 |
D/D |
1,000 |
30,298 |
2.73 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2020-02-04 |
4 |
B |
$4.24 |
$2,120 |
D/D |
500 |
63,090 |
2.73 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2021-04-15 |
4 |
B |
$2.24 |
$2,240 |
D/D |
1,000 |
29,298 |
2.73 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2023-09-26 |
4 |
B |
$0.90 |
$2,250 |
D/D |
2,500 |
55,377 |
2.73 |
- |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2023-04-25 |
4 |
B |
$1.89 |
$2,485 |
D/D |
1,315 |
5,513 |
2.73 |
- |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2023-04-26 |
4 |
B |
$1.77 |
$2,650 |
D/D |
1,497 |
7,010 |
2.73 |
- |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2022-06-29 |
4 |
B |
$0.42 |
$2,908 |
D/D |
7,000 |
217,058 |
2.73 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2022-03-15 |
4 |
B |
$0.98 |
$2,940 |
D/D |
3,000 |
208,058 |
2.73 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2021-03-25 |
4 |
B |
$3.25 |
$4,875 |
D/D |
1,500 |
25,798 |
2.73 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2021-10-22 |
4 |
B |
$1.90 |
$5,700 |
D/D |
3,000 |
36,298 |
2.81 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2021-10-19 |
4 |
B |
$1.91 |
$5,730 |
D/D |
3,000 |
33,298 |
2.81 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2020-05-22 |
4 |
B |
$7.25 |
$15,000 |
D/D |
2,069 |
23,548 |
2.81 |
% |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2016-10-28 |
4 |
B |
$2.05 |
$15,381 |
D/D |
7,500 |
7,500 |
2.81 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2013-11-01 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2013-12-02 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-01-02 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-02-11 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-03-31 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-04-30 |
4 |
OE |
$13.01 |
$29,273 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
President and CEO |
• • – |
2018-12-28 |
4 |
D |
$5.00 |
$77,765 |
D/D |
(15,553) |
83,982 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-04-30 |
4 |
AS |
$43.18 |
$97,998 |
D/D |
(2,250) |
0 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-03-31 |
4 |
AS |
$45.84 |
$103,947 |
D/D |
(2,250) |
0 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2014-02-11 |
4 |
AS |
$67.00 |
$150,750 |
D/D |
(2,250) |
0 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Pres., US/Int. Comm. & Manuf. |
• – – |
2013-12-02 |
4 |
AS |
$70.10 |
$158,423 |
D/D |
(2,250) |
0 |
0 |
- |
|
54 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
